<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There is a growing interest in studying cell cycle and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>p53 has been a major target of several studies </plain></SENT>
<SENT sid="2" pm="."><plain>We examined the impact of antibody selection on p53 overexpression in bone marrow (BM) biopsies of 28 patients with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA) in addition to 10 cases of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AA) using three antibodies DO-7, PAb 1801, and PAb 240 </plain></SENT>
<SENT sid="3" pm="."><plain>DO-7 was positive in 68%, PAb 1801 in 18% and PAb240 in 4% of RA patients </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> three antibodies were negative in AA </plain></SENT>
<SENT sid="5" pm="."><plain>We conclude that antibody selection is an important variable in studying p53 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> regardless of the method of fixation or <z:mpath ids='MPATH_48'>decalcification</z:mpath> of BM trephine biopsies </plain></SENT>
</text></document>